ROSEN, SKILLED INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AGL

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Agilon Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Agilon securities between February 26, 2025, and August 4, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by March 2, 2026 [3] - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [4] Group 3: Case Allegations - The lawsuit alleges that Agilon's defendants made false or misleading statements and failed to disclose critical information regarding their 2025 guidance and the financial impact of strategic actions taken [5] - It is claimed that the defendants were aware of material industry headwinds that would prevent achieving their guidance, leading to materially false statements about Agilon's business and prospects [5] - The lawsuit asserts that when the true information became public, investors suffered damages as a result [5]